Funding
Strategic · Healthtech

HistoSonics receives strategic financing for histotripsy technology

Reed Jobs and Yosemite participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

HistoSonics received strategic financing on June 22, with Reed Jobs and Yosemite named as participants. Financial terms were not disclosed. The company develops focused-ultrasound histotripsy systems for mechanical tumor destruction.

Funding history

Strategic · This roundUndisclosed

Sources

  1. HistoSonicsprojectstartups.com
  2. businesswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related